Label: SRONYX- levonorgestrel and ethinyl estradiol kit

  • NDC Code(s): 75907-089-28, 75907-089-55
  • Packager: Dr. Reddy's Labratories Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated September 20, 2024

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION
    PHYSICIAN LABELING - Rx only - Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.
  • DESCRIPTION
    Each cycle of Sronyx - ®(Levonorgestrel and Ethinyl Estradiol Tablets USP) consists of 21 white active tablets each containing 0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol; and seven peach ...
  • CLINICAL PHARMACOLOGY
    Combination oral contraceptives act by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical ...
  • INDICATIONS AND USAGE
    Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table III lists the ...
  • CONTRAINDICATIONS
    Levonorgestrel and ethinyl estradiol tablets are contraindicated in females who are known to have or develop the following conditions: Thrombophlebitis or thromboembolic disorders - A past history ...
  • WARNINGS
    Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and ...
  • PRECAUTIONS
    1. GENERAL - Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. 2. PHYSICAL EXAMINATION AND FOLLOW-UP - It ...
  • ADVERSE REACTIONS
    Post Marketing Experience - Five studies that compared breast cancer risk between ever-users (current or past use) of COCs and never-users of COCs reported no association between ever use of COCs ...
  • OVERDOSAGE
    Serious ill effects have not been reported following acute ingestion of large doses of oral contraceptives by young children. Overdosage may cause nausea, and withdrawal bleeding may occur in ...
  • NON-CONTRACEPTIVE HEALTH BENEFITS
    The following non-contraceptive health benefits related to the use of oral contraceptives are supported by epidemiological studies which largely utilized oral contraceptive formulations containing ...
  • DOSAGE AND ADMINISTRATION
    Sronyx - ®(Levonorgestrel and Ethinyl Estradiol Tablets USP) To achieve maximum contraceptive effectiveness, Sronyx must be taken exactly as directed at intervals not exceeding ...
  • HOW SUPPLIED
    Sronyx - ®is available in a 28 Tablet Dispenser (75907-089-28), arranged in 3 rows of 7 active tablets and 1 row of inert tablets, as follows: 21 active tablets: white, round tablet debossed ...
  • PATIENT PACKAGE INSERT
    BRIEF SUMMARY - PATIENT PACKAGE INSERT - This product (like all oral contraceptives) is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually ...
  • INSTRUCTIONS FOR USE
    INSTRUCTIONS TO PATIENTS - HOW TO TAKE THE PILL - IMPORTANT POINTS TO REMEMBER - BEFOREYOU START TAKING YOUR PILLS: BE SURE TO READ THESE DIRECTIONS: Before you start taking your ...
  • PATIENT PACKAGE INSERT
    DETAILED PATIENT PACKAGE INSERT - This product (like all oral contraceptives) is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually ...
  • PRINCIPAL DISPLAY PANEL - Kit Carton
    NDC 75907-089-55 - Sronyx - ® Levonorgestrel and Ethinyl Estradiol - Tablets USP - 28-DAY REGIMEN - This product (like all oral contraceptives) is intended to prevent - pregnancy. It does ...
  • INGREDIENTS AND APPEARANCE
    Product Information